STOCK TITAN

Adtalem Global Ed (ATGE) Stock News

ATGE NYSE

Welcome to our dedicated page for Adtalem Global Ed news (Ticker: ATGE), a resource for investors and traders seeking the latest updates and insights on Adtalem Global Ed stock.

Covista Inc., formerly Adtalem Global Education Inc. (ATGE), reports developments tied to its healthcare education business and completed corporate rebranding. News about the company centers on enrollment trends, earnings results, strategic planning, and the role of its institutions in preparing healthcare professionals for the U.S. workforce.

Recurring updates cover Chamberlain University, Walden University, Ross University School of Medicine, academic program expansion, technology-enabled curriculum initiatives, healthcare workforce research, and leadership changes at operating institutions. Corporate news also documents the transition from Adtalem to Covista and the company’s move from ATGE to the CVSA ticker on the New York Stock Exchange.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-30.86%
Tags
-
Rhea-AI Summary

Adtalem Global Education (NASDAQ:ATGE) is expanding pathways into medical school to help address a projected global health workforce shortfall. Key initiatives include Advanced Medical Preparation (AMP) India feeding into Ross University School of Medicine in Barbados, a guaranteed-admission route from a two-year accelerated BSc at University of Wolverhampton into American University of the Caribbean, and a U.S. partnership with ScribeAmerica offering conditional acceptances plus layered scholarship support.

The schools reported a 95% first-time residency attainment rate (2024-25). The ScribeAmerica pathway is open to ~10,000 eligible employees with no participation cap.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.53%
Tags
none
-
Rhea-AI Summary

Adtalem Global Education (NYSE: ATGE) and Google Cloud announced a strategic partnership to launch a scalable AI credentials program for healthcare professionals, beginning in 2026. The curriculum will use Google Cloud AI technologies including Gemini and Vertex AI and aims to train students and practicing clinicians across Adtalem institutions that collectively serve over 91,000 students. The program covers clinical AI applications, ethics, patient safety, and hands-on tool experience, and will be offered as continuing education with flexible coursework for working clinicians.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.69%
Tags
AI
Rhea-AI Summary

Adtalem Global Education (NYSE:ATGE), America's leading healthcare educator, has scheduled its first quarter fiscal 2026 earnings release for October 30, 2025, after market close. The company will host a conference call at 4:00 p.m. CT (5:00 p.m. ET) to discuss the results.

Participants can join via phone using the toll-free number for U.S. callers or international line, or access the simulcast through Adtalem's investor relations website. A 30-day replay will be available through both phone and web platforms.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.22%
Tags
conferences earnings
-
Rhea-AI Summary

Adtalem Global Education (NYSE:ATGE), the leading healthcare educator in the United States, has announced its participation in two upcoming investor conferences in September 2025. CFO Bob Phelan will attend the 18th Annual Barrington Research Virtual Fall Investment Conference on September 16 for one-on-one investor meetings. Additionally, CEO Steve Beard and Phelan will present at the Jefferies Healthcare Services Conference in Nashville on September 30 at 1:50 p.m. CT. The Jefferies presentation will be available via live webcast and replay on Adtalem's investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.36%
Tags
conferences
-
Rhea-AI Summary

Adtalem Global Education (NYSE:ATGE) reported exceptional fiscal year 2025 results, with revenue increasing 12.9% year-over-year to $1.79 billion. The company achieved significant growth across all segments, with total enrollment up 10.2% YoY in Q4 2025.

Key highlights include adjusted EPS of $6.67 (up 33.1% YoY), adjusted EBITDA of $459.7 million (up 21.8% YoY), and record enrollments at Chamberlain (40,500+ students) and Walden (48,500+ students). The company demonstrated strong capital allocation, repurchasing $211 million of shares and maintaining a healthy net leverage ratio of 0.8x.

Looking ahead, Adtalem provided FY2026 guidance with revenue projected between $1.9-$1.94 billion and adjusted EPS of $7.60-$7.90, representing growth of 6.0-8.5% and 14.0-18.5% respectively.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.19%
Tags
Rhea-AI Summary

Sallie Mae (NASDAQ:SLM) and Adtalem Global Education (NYSE:ATGE) have signed a Letter of Intent to develop alternative student financing solutions ahead of the federal Grad PLUS loan program phase-out in July 2026. The initiative aims to support healthcare students across Adtalem's five institutions, which serve over 90,000 students.

The partnership comes amid significant healthcare workforce shortages, with projections showing a physician deficit of up to 124,000 by 2034 and over 7,000 areas designated as Health Professional Shortage Areas. The companies plan to create tailored financing solutions with deferred repayment options and degree-specific terms, with final agreements expected in the coming months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.89%
Tags
none
-
Rhea-AI Summary

Adtalem Global Education (NYSE:ATGE) announced a groundbreaking partnership between its Chamberlain University and SSM Health to address the critical nursing shortage across four states. The innovative Aspiring Nurse Program combines tuition support, clinical training, and guaranteed employment opportunities, projected to produce over 400 new nurses annually.

The program will launch in Oklahoma through Chamberlain's online BSN program in Fall 2025, with subsequent expansions to Missouri, Illinois, and Wisconsin. Students will receive hands-on training at SSM Health facilities and commit to joining their workforce post-graduation, creating a sustainable talent pipeline. The partnership represents Adtalem's strategic move to become the leading clinical workforce partner for healthcare providers nationwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.33%
Tags
partnership
-
Rhea-AI Summary

Adtalem Global Education (NYSE:ATGE), the leading healthcare educator in the United States, has scheduled its fourth quarter and fiscal year 2025 earnings release and conference call. The company will release results on Thursday, August 7, 2025, after market close, followed by a conference call at 4:00 p.m. CT (5:00 p.m. ET).

Investors can access the call via phone using the provided U.S. and international dial-in numbers or through a simulcast on the company's investor relations website. A replay will be available for 30 days following the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.13%
Tags
conferences earnings
Rhea-AI Summary

Adtalem Global Education (NYSE: ATGE), the leading healthcare educator in the United States, has announced its participation in the Baird 2025 Global Consumer, Technology & Services Conference. Chairman and CEO Steve Beard, along with CFO Bob Phelan, will engage in a fireside chat on June 4, 2025, at 3:45 p.m. ET in New York City. The discussion will focus on the company's strategic investments in its innovative education model, which is tailored for modern students and aims to address nationwide clinician shortages. The presentation will be accessible live and available for replay through the company's investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.13%
Tags
conferences

FAQ

What is the current stock price of Adtalem Global Ed (ATGE)?

The current stock price of Adtalem Global Ed (ATGE) is $98.5 as of February 24, 2026.

What is the market cap of Adtalem Global Ed (ATGE)?

The market cap of Adtalem Global Ed (ATGE) is approximately 3.4B.